AORT: Artivion Inc

AORT News

• 14:52 Artivion Inc stock hits 52-week high at 44.01 USD
• 11:47 Artivion stock price target raised to $50 from $45 at Needham
• 19:54 Artivion stock hits 52-week high at 43.93 USD
• 16:09 Artivion at Canaccord Conference: Strategic Growth and Innovation
• 14:52 Artivion stock price target raised by Stifel to $40 on strong AMDS launch
• 14:31 Tesla and Palantir Lead Mega-Cap Stock Movers on Friday
• 12:01 Needham raises Artivion stock price target to $45 on growth acceleration
• 11:30 Artivion stock price target raised to $41 from $35 at Canaccord on strong Q2
• 10:53 Oppenheimer lowers Artivion stock price target to $40 from $42, maintains Outperform
• 10:52 Oppenheimer raises Artivion stock price target to $40 on strong Q2 results
• 09:25 Artivion Q2 2025 slides: Revenue jumps 14%, guidance raised on strong product growth
• 08:58 Artivion stock price target raised to $42 from $33 at JMP on strong growth
• 22:16 Artivion (AORT) Q2 2025 Earnings Call Transcript
• 22:05 Artivion (AORT) Tops Q2 Earnings and Revenue Estimates
• 20:22 Artivion earnings beat by $0.24, revenue topped estimates
• 14:31 Stifel raises Artivion stock price target to $36 on positive AMDS feedback
• 14:07 Artivion stock reaches 52-week high at 33.16 USD
• 21:20 Penumbra (PEN) Surpasses Q2 Earnings and Revenue Estimates
• 09:09 Citizens JMP reiterates Market Outperform rating on Artivion stock
• 13:56 Artivion Inc stock reaches 52-week high at 32.38 USD
• 19:18 NYLI WMC Small Companies Fund Q1 2025 Commentary
• 13:01 Artivion at 2025 Truist MedTech Conference: Aortic Strategy Unveiled
• 09:53 Canaccord Genuity initiates Artivion stock with buy rating on aortic repair bets
• 20:32 Artivion to Participate in Upcoming Investor Conferences